Publication | Closed Access

Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone

Molecular PharmacologyMetabolic SyndromeBiochemistryMedicinePhysiologyDiabetesMechanism Of ActionReceptor (Biochemistry)Adverse EffectsClinical PharmacologyExperimental PharmacologyPharmacotherapyPharmacologyHealth Sciences